Molecular regulation of the renin–angiotensin system in haemodialysis patients-Reference-Cited by-同舟云学术

Molecular regulation of the renin–angiotensin system in haemodialysis patients

Published:2014-08-08 Issue:1 Volume:30 Page:115-123
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Kovarik Johannes J.,Antlanger Marlies,Domenig Oliver,Kaltenecker Christopher C.,Hecking Manfred,Haidinger Michael,Werzowa Johannes,Kopecky Chantal,Säemann Marcus D.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/30/1/115/17171546/gfu265.pdf

Reference34 articles.

1. Biomarkers of inflammation and progression of chronic kidney disease;Tonelli;Kidney Int,2005

2. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study;Bajaj;Arch Intern Med,2012

3. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis;Suzuki;Ther Adv Cardiovasc Dis,2009

4. ACE inhibitors and survival of hemodialysis patients;Efrati;Am J Kidney Dis,2002

5. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies;Zannad;Kidney Int,2006

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intra- and postoperative relative angiotensin II deficiency in patients undergoing elective major abdominal surgery;Frontiers in Endocrinology;2024-07-08

2. Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study;Renal Failure;2024-03-24

3. Antihypertensive treatment of end-stage renal disease patients on hemodialysis does not alter circulating ACE and ACE2 activity and angiotensin peptides;The American Journal of the Medical Sciences;2024-02

4. Angiotensin-II Use for Refractory Hypotension in an Infant With Bilateral Renal Agenesis;Pediatrics;2023-12-15

5. Effect of renin–angiotensin system inhibitors on cardiovascular events in hemodialysis patients with hyperphosphatemia: A post hoc analysis of the LANDMARK trial;Therapeutic Apheresis and Dialysis;2023-11-03